估计帕金森病中生物标志物变化的序列
Yaqin Xiang1, XiuRong Huang1, Qian Xu1
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Parkinsonism & related disorders
|November 29, 2023
概括
这项研究揭示了帕金森病 (PD) 中最早的生物标志物变化. 左膜异常在其他标志物之前,使用数据驱动模型提供了对PD进展的见解.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物研究 生物标志物研究
- 数据科学数据科学数据科学
背景情况:
- 帕金森病 (PD) 的诊断和进展监测依赖于确定可靠的生物标志物.
- 了解生物标志物变化的时间序列对于早期检测和治疗开发至关重要.
研究的目的:
- 通过一种新的数据驱动方法,估计帕金森病 (PD) 中常见生物标志物变化的序列.
- 建立基于生物标志物变化的PD疾病进展时间表.
主要方法:
- 在374名PD患者和169名健康对照 (HC) 的数据上使用了基于事件的歧视模型 (DEBM).
- 分析的生物标志物包括左侧和右侧膜和尾膜的条状结合比 (SBR),脑脊液 (CSF) 的α-synuclein和血清神经丝轻链 (NfL).
- 与临床PD症状相关的估计疾病阶段.
主要成果:
- 左门SBR被确定为最早的异常生物标志物,其次是右门,脑脊液α-synuclein,右尾状SBR,左尾状SBR和血清NfL.
- 在区分PD和HC时,DEBM实现了高精度 (AUC为0.98).
- 估计的疾病阶段与PD患者的运动症状,自主功能障碍和焦虑有显著的相关性.
结论:
- 使用DEBM确定了PD中常见生物标志物变化的序列.
- 为帕金森病的疾病进展时间表提供了数据驱动的证据.
- 通过生物标志物分析建立了一个可靠的模型来跟踪PD进展.
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557


